Cargando…
The Promise of Single-cell Technology in Providing New Insights Into the Molecular Heterogeneity and Management of Acute Lymphoblastic Leukemia
Drug resistance and treatment failure in pediatric acute lymphoblastic leukemia (ALL) are in part driven by tumor heterogeneity and clonal evolution. Although bulk tumor genomic analyses have provided some insight into these processes, single-cell sequencing has emerged as a powerful technique to pr...
Autores principales: | Pearson, Holly C.L., Hunt, Kooper V., Trahair, Toby N., Lock, Richard B., Lee, Heather J., de Bock, Charles E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148686/ https://www.ncbi.nlm.nih.gov/pubmed/35651714 http://dx.doi.org/10.1097/HS9.0000000000000734 |
Ejemplares similares
-
Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia
por: Bhadri, Vivek A, et al.
Publicado: (2011) -
Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia
por: Yadav, Babasaheb D., et al.
Publicado: (2016) -
DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia
por: Sexauer, Amy N., et al.
Publicado: (2023) -
Exploring the Metabolic Landscape of AML: From Haematopoietic Stem Cells to Myeloblasts and Leukaemic Stem Cells
por: Mesbahi, Yashar, et al.
Publicado: (2022) -
Circulating Tumor DNA in Pediatric Cancer
por: Doculara, Louise, et al.
Publicado: (2022)